Global medtech is entering a phase where growth, scale, and innovation alone are no longer enough. As care shifts beyond hospitals, outcomes and data increasingly define value, and capital becomes more selective, companies must reassess where they can truly compete. Global Medtech 2026: The Year of the Intelligent Pivot examines how these structural changes are reshaping surgical markets, corporate portfolios, and competitive advantage, and why focus, rather than breadth, is emerging as the most durable strategy for the year ahead.